Page last updated: 2024-09-03

galactosyl-(1-3)galactose and Kaposi Sarcoma

galactosyl-(1-3)galactose has been researched along with Kaposi Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Larkin, JM; Porter, CD	1

Other Studies

1 other study(ies) available for galactosyl-(1-3)galactose and Kaposi Sarcoma

Article	Year
Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy. Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:1 Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Complement System Proteins; Cytotoxicity, Immunologic; Disaccharides; Disease Models, Animal; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Galactosyltransferases; Graft Rejection; Humans; Immune Tolerance; Immunoglobulin M; Mice; Mice, Knockout; Mice, Nude; Rabbits; Retroviridae; Sarcoma, Kaposi; Transplantation, Heterologous	2007

Article

Year

Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.

Cancer immunology, immunotherapy : CII, 2007, Volume: 56, Issue:1

Topics: Animals; Antibody-Dependent Cell Cytotoxicity; Complement System Proteins; Cytotoxicity, Immunologic; Disaccharides; Disease Models, Animal; Endothelium, Vascular; Enzyme-Linked Immunosorbent Assay; Galactosyltransferases; Graft Rejection; Humans; Immune Tolerance; Immunoglobulin M; Mice; Mice, Knockout; Mice, Nude; Rabbits; Retroviridae; Sarcoma, Kaposi; Transplantation, Heterologous

2007